Peer Review History
| Original SubmissionJuly 6, 2023 |
|---|
|
PONE-D-23-11476Developing a Strategy to Scale up Place-Based Arts Initiatives that Support Mental Health and Wellbeing: A Realist Evaluation of ‘Arts for the Blues’PLOS ONE Dear Dr. Karkou, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 17 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Soham Bandyopadhyay Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: "2022-01-31 to 2023-01-30 | Grant Arts and Humanities Research Council (Swindon, GB) GRANT_NUMBER: AH/W007983/1" Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This paper addresses the important issue of the scalability and spread of arts and health interventions. Overall, this paper proposes a plausible and relevant set of considerations to guide stakeholders, including policymakers, health care organisations, community partners, and professionals/practitioners involved in delivering arts and health programmes. It is well-written and accessible to a general audience. However, the overall argument of the paper regarding adaptation and scale-up is fundamentally weakened by the following issues: 1. Fidelity to the original intervention and its associated evidence base is a key element of scaling up an intervention that promises and intends to achieve similar outcomes. Theoretical assumption (i) first described on P11 suggests that a simplified version of the Arts for the Blues programme delivered by different practitioners/those with less experience will support spread and adoption. However, the model programme, as described in reference 20, is based on“arts-based or creative psychotherapy […] practices delivered by a range of qualified therapists including arts and expressive psychotherapists.” Neither that paper nor the paper under review describe an adaptation that could be equivalently delivered by non-therapists or artists. This is problematic on several points: a. The model programme described in reference 20 contains several elements that involve the elicitation and management of emotional material that may require the guidance or support of a trained therapist. Many non-therapists lack the technical skill to practice in a way that is emotionally safe for either themselves or their participants. Most non-therapists would be reluctant to take on this responsibility. In particular, artists are quite clear that they do not want to be therapists when working in a health and wellbeing context. In addition to the potential patient risks that concern many NHS and social prescribing stakeholders (as described in this paper, eg P15), artists themselves may suffer when confronted with their participants’ emotional distress. Also troubling is the suggestion that the intervention could be "Not only facilitated by professionals but also used by individuals on their own." (P17) b. Many of the stakeholders cited in this paper are concerned with having a solid evidence base for adopting new interventions. The evidence for the initial programme was based on being delivered by arts therapists who are trained to provide emotional support. Since there is no discussion of the mechanisms that deliver the desired outcomes (is it the art? or the psychotherapeutic support?), we cannot assume that an adaptation delivered by non-therapists will produce the same outcomes. This ambiguity/contradiction becomes problematic in the discussion on the evidence base on PP16 and 17 and at other points in the paper. These challenges are not adequately addressed in the later discussion. Final approval of this paper should be contingent on a more detailed explanation of the essential elements and mechanisms of the programme’s adaptation, addressing the training and skills to required to deliver the intervention and whether non-therapists can manage complex emotional needs that may arise, and resolving the fidelity/adaptation/evidence contradictions raised above. Because some of the quotes provided as evidence do not always support the associated points, consideration should also be given to the additional items below. Specific points or questions: P13: are the dates for the events stated correctly here? P13: what does ‘work closely’ with PPIE group mean? – their viewpoints are not included in this paper. P18 after (ii) through the first paragraph on P19 – these seems like a description of methods that have already be relayed at the top of the findings section and in the methods. Similarly, the context is missing in in the first paragraphs after (iv) on P22. Vertical activities related to what? Overall, it’s not clear how the general assertions about the historical project fit alongside data resulting from the specific stakeholder activities you describe in the methods. Is the data you’re presenting in support of your assumptions both from the years of project implementation or the stakeholder events or both? This exposition style should be made clear at the outset of your discussion of the assumptions. P 19: under the finding of Need – this quote begs the question of whether there is any impact on GP visits from this intervention. And more broadly – meeting whose needs? Health service utilisation targets or addressing patients’ mental health needs? . P 19: Under the topic Understanding, the artist quote ironically reinforces the point made on P16 about having a biased professional perspective. I’m also not convinced of the point the second quote makes. P19: The quotes under Resources are similarly unconvincing, and in direct contradiction with the resource issues raised in the Challenges section. P19: Under Inspiration, is the training an example of something that facilitates scale-up? Is this inspiration or skills-building? Perhaps this is better placed under “Help”. P21: The first sentence beginning “Rules and guidelines…” does not say how the project does address rules and guidelines. I’m not sure how the subsequent quote relates to the intervention meeting required standards. P21: the first quote for the section on Early Intervention is not about that subject. P23, near the bottom: “Expanding the potential use” – this sentence is a statement without substantiation. P24: I think the quote related to Diverse communities is ambiguous and possibly subject to misinterpretation. Also, what is a ‘south western community’? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Developing a Strategy to Scale up Place-Based Arts Initiatives that Support Mental Health and Wellbeing: A Realist Evaluation of ‘Arts for the Blues’ PONE-D-23-11476R1 Dear Dr. Karkou We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Soham Bandyopadhyay Academic Editor PLOS ONE Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have taken time and care in responding to the reviewer comments. This article will contribute much to the ongoing discussion on this topic. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** |
| Formally Accepted |
|
PONE-D-23-11476R1 PLOS ONE Dear Dr. Karkou, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Soham Bandyopadhyay Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .